A cross-sectional study of female sexual function and dysfunction during pregnancy

Bulent Erol, Oner Sanli, Duzgun Korkmaz, Ayse Seyhan, Tolga Akman, Ates Kadioglu

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Introduction. Although women may undergo changes in sexual function during pregnancy, there are limited studies correlating possible sexual function changes to androgen blood levels during the pregnancy. Aim. Tosearch for a possible correlation, we performed a cross-sectional observational study to assess sexual function scores and androgen blood levels of women during pregnancy. Materials and Methods. A total of 589 healthy pregnant women were recruited to the present cross-sectional study. Of these patients, 116 (19.6%), 220 (37.3%), and 253 (42.9%) were in their first, second, and third trimesters, respectively. They were evaluated with a detailed medical and sexual history, including IFSF questionnaire. In addition, maternal serum androgen levels (testosterone, dehydroepiandrosterone sulphate, free testosterone) were determined in each trimester during regular follow-ups. Main Outcome Measures. Assessment of Index of Female Sexual Function (IFSF) domains and serum androgen levels in each trimester. Results. The mean age of the three groups were similar (P > 0.05). Overall, total IFSF scores of women in the first and second trimesters were 21.4 ± 10.1 and 22.3 ± 10, respectively, while it was 15.9 ± 12.3 during the third trimester (P < 0.05). The most common sexual dysfunction symptom was diminished clitoral sensation, observed in 94.2% of the patients, followed by lack of libido in 92.6% and orgasmic disorder in 81%. No correlation was detected between total IFSF score and serum androgen levels. Conclusion. In this cross-sectional study, we noted lower sexual function scores in women in the third trimester of their pregnancies compared with those in their first two trimesters of pregnancy. These lower sexual function scores in the third trimester were not associated with lower androgen levels. We plan to perform a future prospective study to better assess both the change in sexual function and also its possible relation to androgen levels in pregnant women.

Original languageEnglish (US)
Pages (from-to)1381-1387
Number of pages7
JournalJournal of Sexual Medicine
Volume4
Issue number5
DOIs
StatePublished - Jan 1 2007

Fingerprint

Androgens
Cross-Sectional Studies
Pregnancy
Third Pregnancy Trimester
First Pregnancy Trimester
Second Pregnancy Trimester
Testosterone
Pregnant Women
Serum
Psychological Sexual Dysfunctions
Libido
Dehydroepiandrosterone Sulfate
Observational Studies
Age Groups
Mothers
Outcome Assessment (Health Care)
Prospective Studies

Keywords

  • Androgens
  • Female Sexuality
  • Pregnancy

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Urology

Cite this

A cross-sectional study of female sexual function and dysfunction during pregnancy. / Erol, Bulent; Sanli, Oner; Korkmaz, Duzgun; Seyhan, Ayse; Akman, Tolga; Kadioglu, Ates.

In: Journal of Sexual Medicine, Vol. 4, No. 5, 01.01.2007, p. 1381-1387.

Research output: Contribution to journalArticle

Erol, Bulent ; Sanli, Oner ; Korkmaz, Duzgun ; Seyhan, Ayse ; Akman, Tolga ; Kadioglu, Ates. / A cross-sectional study of female sexual function and dysfunction during pregnancy. In: Journal of Sexual Medicine. 2007 ; Vol. 4, No. 5. pp. 1381-1387.
@article{ab9eff9ad82d47fa806764fb00ecac98,
title = "A cross-sectional study of female sexual function and dysfunction during pregnancy",
abstract = "Introduction. Although women may undergo changes in sexual function during pregnancy, there are limited studies correlating possible sexual function changes to androgen blood levels during the pregnancy. Aim. Tosearch for a possible correlation, we performed a cross-sectional observational study to assess sexual function scores and androgen blood levels of women during pregnancy. Materials and Methods. A total of 589 healthy pregnant women were recruited to the present cross-sectional study. Of these patients, 116 (19.6{\%}), 220 (37.3{\%}), and 253 (42.9{\%}) were in their first, second, and third trimesters, respectively. They were evaluated with a detailed medical and sexual history, including IFSF questionnaire. In addition, maternal serum androgen levels (testosterone, dehydroepiandrosterone sulphate, free testosterone) were determined in each trimester during regular follow-ups. Main Outcome Measures. Assessment of Index of Female Sexual Function (IFSF) domains and serum androgen levels in each trimester. Results. The mean age of the three groups were similar (P > 0.05). Overall, total IFSF scores of women in the first and second trimesters were 21.4 ± 10.1 and 22.3 ± 10, respectively, while it was 15.9 ± 12.3 during the third trimester (P < 0.05). The most common sexual dysfunction symptom was diminished clitoral sensation, observed in 94.2{\%} of the patients, followed by lack of libido in 92.6{\%} and orgasmic disorder in 81{\%}. No correlation was detected between total IFSF score and serum androgen levels. Conclusion. In this cross-sectional study, we noted lower sexual function scores in women in the third trimester of their pregnancies compared with those in their first two trimesters of pregnancy. These lower sexual function scores in the third trimester were not associated with lower androgen levels. We plan to perform a future prospective study to better assess both the change in sexual function and also its possible relation to androgen levels in pregnant women.",
keywords = "Androgens, Female Sexuality, Pregnancy",
author = "Bulent Erol and Oner Sanli and Duzgun Korkmaz and Ayse Seyhan and Tolga Akman and Ates Kadioglu",
year = "2007",
month = "1",
day = "1",
doi = "10.1111/j.1743-6109.2007.00559.x",
language = "English (US)",
volume = "4",
pages = "1381--1387",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - A cross-sectional study of female sexual function and dysfunction during pregnancy

AU - Erol, Bulent

AU - Sanli, Oner

AU - Korkmaz, Duzgun

AU - Seyhan, Ayse

AU - Akman, Tolga

AU - Kadioglu, Ates

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Introduction. Although women may undergo changes in sexual function during pregnancy, there are limited studies correlating possible sexual function changes to androgen blood levels during the pregnancy. Aim. Tosearch for a possible correlation, we performed a cross-sectional observational study to assess sexual function scores and androgen blood levels of women during pregnancy. Materials and Methods. A total of 589 healthy pregnant women were recruited to the present cross-sectional study. Of these patients, 116 (19.6%), 220 (37.3%), and 253 (42.9%) were in their first, second, and third trimesters, respectively. They were evaluated with a detailed medical and sexual history, including IFSF questionnaire. In addition, maternal serum androgen levels (testosterone, dehydroepiandrosterone sulphate, free testosterone) were determined in each trimester during regular follow-ups. Main Outcome Measures. Assessment of Index of Female Sexual Function (IFSF) domains and serum androgen levels in each trimester. Results. The mean age of the three groups were similar (P > 0.05). Overall, total IFSF scores of women in the first and second trimesters were 21.4 ± 10.1 and 22.3 ± 10, respectively, while it was 15.9 ± 12.3 during the third trimester (P < 0.05). The most common sexual dysfunction symptom was diminished clitoral sensation, observed in 94.2% of the patients, followed by lack of libido in 92.6% and orgasmic disorder in 81%. No correlation was detected between total IFSF score and serum androgen levels. Conclusion. In this cross-sectional study, we noted lower sexual function scores in women in the third trimester of their pregnancies compared with those in their first two trimesters of pregnancy. These lower sexual function scores in the third trimester were not associated with lower androgen levels. We plan to perform a future prospective study to better assess both the change in sexual function and also its possible relation to androgen levels in pregnant women.

AB - Introduction. Although women may undergo changes in sexual function during pregnancy, there are limited studies correlating possible sexual function changes to androgen blood levels during the pregnancy. Aim. Tosearch for a possible correlation, we performed a cross-sectional observational study to assess sexual function scores and androgen blood levels of women during pregnancy. Materials and Methods. A total of 589 healthy pregnant women were recruited to the present cross-sectional study. Of these patients, 116 (19.6%), 220 (37.3%), and 253 (42.9%) were in their first, second, and third trimesters, respectively. They were evaluated with a detailed medical and sexual history, including IFSF questionnaire. In addition, maternal serum androgen levels (testosterone, dehydroepiandrosterone sulphate, free testosterone) were determined in each trimester during regular follow-ups. Main Outcome Measures. Assessment of Index of Female Sexual Function (IFSF) domains and serum androgen levels in each trimester. Results. The mean age of the three groups were similar (P > 0.05). Overall, total IFSF scores of women in the first and second trimesters were 21.4 ± 10.1 and 22.3 ± 10, respectively, while it was 15.9 ± 12.3 during the third trimester (P < 0.05). The most common sexual dysfunction symptom was diminished clitoral sensation, observed in 94.2% of the patients, followed by lack of libido in 92.6% and orgasmic disorder in 81%. No correlation was detected between total IFSF score and serum androgen levels. Conclusion. In this cross-sectional study, we noted lower sexual function scores in women in the third trimester of their pregnancies compared with those in their first two trimesters of pregnancy. These lower sexual function scores in the third trimester were not associated with lower androgen levels. We plan to perform a future prospective study to better assess both the change in sexual function and also its possible relation to androgen levels in pregnant women.

KW - Androgens

KW - Female Sexuality

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=34548304076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548304076&partnerID=8YFLogxK

U2 - 10.1111/j.1743-6109.2007.00559.x

DO - 10.1111/j.1743-6109.2007.00559.x

M3 - Article

C2 - 17651387

AN - SCOPUS:34548304076

VL - 4

SP - 1381

EP - 1387

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 5

ER -